These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1653676)

  • 21. Glycosylated serum proteins in diabetic patients and their relation to metabolic parameters.
    Lapolla A; Poli T; Valerio A; Fedele D
    Diabete Metab; 1985 Aug; 11(4):238-42. PubMed ID: 4043491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in glycosylated proteins in diabetic and non-diabetic patients with and without cardiovascular complications.
    Gul A; Rahman MA
    Asia Pac J Clin Nutr; 2003; 12(3):277-81. PubMed ID: 14505990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycated serum protein determination: comparison between thiobarbituric acid and fructosamine assays.
    Poli T; Lapolla A; Plebani M; Franchin A; Fedele D
    Acta Diabetol Lat; 1987; 24(3):241-7. PubMed ID: 3687316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycosylated albumin and glycosylated proteins: rapidly changing indices of glycaemia in diabetic pregnancy.
    Leiper JM; Talwar D; Robb DA; Lunan CB; MacCuish AC
    Q J Med; 1985 Jun; 55(218):225-31. PubMed ID: 4023170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-lysine reduces the non-enzymatic glycation of proteins in experimental diabetes mellitus in rats.
    Sensi M; De Rossi MG; Celi FS; Cristina A; Rosati C; Perrett D; Andreani D; Di Mario U
    Diabetologia; 1993 Sep; 36(9):797-801. PubMed ID: 8405749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glycosylated proteins and control of the diabetic: use of continuous flow insulin pumps by the subcutaneous route].
    Maudelonde T; Menez JF; Meskar A; Tater D; Lucas D; Barbou LG; Bercovici JP
    Diabete Metab; 1983 Sep; 9(3):193-8. PubMed ID: 6653857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study on the levels of glycosylated hemoglobin and fasting plasma glucose in diabetics].
    Xiang KS
    Zhonghua Yi Xue Za Zhi; 1985 Aug; 65(8):449-53. PubMed ID: 3931870
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of insulin-dependent diabetes mellitus (IDDM) duration on superoxide anion and hydrogen peroxide production by polymorphonuclear neutrophils.
    Zozulińska DA; Wierusz-Wysocka B; Wysocki H; Majchrzak AE; Wykretowicz A
    Diabetes Res Clin Pract; 1996 Aug; 33(3):139-44. PubMed ID: 8922534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control.
    Smart LM; Howie AF; Young RJ; Walker SW; Clarke BF; Smith AF
    Diabetes Care; 1988 May; 11(5):433-6. PubMed ID: 3391095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of streptozotocin-induced diabetes in rats by pretreatment with chloroquine.
    Asamoah KA; Furman BL; Robb DA
    Clin Sci (Lond); 1989 Feb; 76(2):137-41. PubMed ID: 2647363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of aldose reductase on the oxidative burst in diabetic neutrophils.
    Tebbs SE; Lumbwe CM; Tesfaye S; Gonzalez AM; Wilson RM
    Diabetes Res Clin Pract; 1992 Feb; 15(2):121-9. PubMed ID: 1314160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two indices of glycemic control in diabetic subjects: glycosylated serum protein and hemoglobin.
    Mehl TD; Wenzel SE; Russell B; Gardner D; Merimee TJ
    Diabetes Care; 1983; 6(1):34-9. PubMed ID: 6839920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].
    Hay U; Sedlmayer A; Müller MM; Dorda W; Schernthaner G
    Klin Wochenschr; 1989 Apr; 67(7):379-85. PubMed ID: 2747138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-performance liquid chromatographic assay of serum glycated albumin.
    Shima K; Ito N; Abe F; Hirota M; Yano M; Yamamoto Y; Uchida T; Noguchi K
    Diabetologia; 1988 Aug; 31(8):627-31. PubMed ID: 3220198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-enzymatic glycosylation of serum proteins as an indicator of diabetic control.
    Gragnoli G; Tanganelli I; Signorini AM; Tarli P; Paoli C
    Acta Diabetol Lat; 1982; 19(2):161-6. PubMed ID: 7051713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus.
    Milsom AB; Jones CJ; Goodfellow J; Frenneaux MP; Peters JR; James PE
    Diabetologia; 2002 Nov; 45(11):1515-22. PubMed ID: 12436334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MPO activity and generation of active O2 species in leukocytes from poorly controlled diabetic patients.
    Sato N; Shimizu H; Suwa K; Shimomura Y; Kobayashi I; Mori M
    Diabetes Care; 1992 Aug; 15(8):1050-2. PubMed ID: 1324143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy.
    Jennings PE; McLaren M; Scott NA; Saniabadi AR; Belch JJ
    Diabet Med; 1991 Nov; 8(9):860-5. PubMed ID: 1837513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Glycosylated serum proteins in the early diagnosis of diabetes mellitus].
    Dosheva I; Shishenkov M; Kalpazanova N; Klechkova L
    Vutr Boles; 1988; 27(3):64-7. PubMed ID: 3206906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation.
    Ceriello A; Giugliano D; Dello Russo P; Tirelli A; Passariello N; Sgambato S
    Diabetes Care; 1986; 9(1):32-5. PubMed ID: 3948645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.